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Present study was carried out on forty four apparently healthy Murrah buﬀaloes of diﬀerent age groups of both sexes to
investigate the eﬀects of sex steroids on cell mediated immunity in vitro. Estrogen inhibited proliferation in mitogen-stimulated
lymphocytes from prepubertal but not post pubertal buﬀaloes of either sex. Estrogen at 100pg/mL concentration stimulating
the proliferation signiﬁcantly (P<0.05). in all groups and had higher stimulatory eﬀect in lymphocytes from day 10 than day
0 of estrous cycle. Progesterone inhibited lymphocyte proliferation, and inhibition was directly related to the dose, in all groups
of either sex. Testosterone did not inhibit proliferation at any dose level and did not show any consistent and lucid eﬀects on
lymphocyte proliferation. Present study revealed that buﬀalo lymphocytes produce appreciable amounts of NO in culture system
after treatment with estradiol. Signiﬁcantly high levels of NO in culture supernatant were found in prepubertal buﬀalo calves and
leastinpostpubertalbuﬀaloes,which hadaninverserelationwithlymphocyteproliferationinpresenceofestradiol.NOinculture
supernatantwashighatthelowestdoseofprogesteronewhichwasproportionaltothelymphocyteproliferationwhentreatedwith
progesterone. No signiﬁcant diﬀerence in NO culture supernatant was observed between diﬀerent concentrations of testosterone
treatment.
1.Introduction
The sex steroids are in use for the last more than a mil-
lennium to correct reproductive disorders and augment
reproductive eﬃciency in animals. However, it has been
increasingly apparent that the eﬀects of sex hormones
extend far beyond their predominant role in sexual dif-
ferentiation and reproduction and are now being realised
as integral signalling modulators of mammalian immune
system. Sexual dimorphism in disease incidence and host
response in wide range of animal species provides an indirect
evidence of role of sexual hormones in immune modulation
[1–3]. Immunological evidence suggests that female sex
hormones play a role in the aetiology and course of chronic
inﬂammatory diseases [4]. The number and activity of
immune cells in reproductive tract of animals and humans
vary signiﬁcantly throughout the phases of the reproductive
cycleandarebelievedtobecontrolledbychangesinthelevels
of estradiol and progesterone hormones [5–7]. Ramadan
et al. [8] in sheep and Wulster-Radcliﬀe et al. [9] in gilts have
reported higher resistance to uterine infections at oestrus
and least during luteal phase. Lymphocyte proliferation
response, a promising marker of host immunity, has been
reported to exhibit variability during various physiological
and reproductive phases in diﬀerent animal species ([10, 11]
in dairy cattle; [12] in hamsters) that has been attributed to
sex hormones. Use of sex steroids or sex steroid blockers or
ovariectomy or castration in animal models for studying the
pathophysiology and immunoendocrinology has provided
direct evidence for the role of sex steroids in immune
modulation [13, 14]. Since there existed species variation in
immune responses to sex steroids, present study was taken
up in buﬀaloes of diﬀerent age, sex, and reproductive phase
wherein phytohemagglutinin- (PHA-) stimulated lympho-
cytes were exposed to diﬀerent concentrations of estrogen,
progesterone, and testosterone to analyse the inﬂuence of2 Veterinary Medicine International
these steroids on proliferation response and nitric oxide
production, which probably is the ﬁrst study of its kind in
buﬀaloes.
2.MaterialsandMethods
Forty-four apparently healthy Murrah buﬀaloes of three age
groups of both sexes (male and female) were selected from
NDRI herd for conducting present experiments. Eighteen
male buﬀaloes were divided into 3 groups of 6 buﬀaloes
on the basis of their age. Group-I included buﬀaloes with
age ranging between 11 and 13 months; group-II consisted
of buﬀaloes with age ranging between 22 and 24 months.
Group-III had postpubertal buﬀaloes 34 and 36 months of
age. Similarly 18 female buﬀaloes were grouped exactly the
same way as in males except that female post pubertal group
had cyclic heifers at day 8–10 of estrous cycle. Eight cyclic
heifers were selected and studied on day 0 and day 10 of
estrous cycle. The estrum (day 0) was conﬁrmed through
rectal palpation by an expert and concerned veterinarian at
the farm. All these Murrah buﬀaloes were maintained under
routine management and nutritional practices as followed
in the herd at the institute. The animal experiments were
acceptable to the ethical standards of the National Dairy
Research Institute, Karnal, India vide IAEC no. 23/09-21/11.
The lymphocytes from peripheral blood were isolated
as per the method followed by Young et al. [15]w i t h
some alterations made by Huozha et al. [16] to suit our
requirements. The proliferative response of lymphocytes was
analysed using the colorimetric MTT (tetrazolium) assay, as
described by [17]. Brieﬂy, about 15mL blood was drawn
from every animal in heparinised vacutainer tubes from
jugular vein, in the morning. Plasma was separated by
centrifugation in refrigeration centrifuge at 2000rpm for
30 minutes. A white buﬀyc o a ta tt h et o po fr e dc o l u m n
was harvested in a new sterile polypropylene centrifuge tube
(15mL) containing Dulbecco’s phosphate buﬀered saline,
(DPBS) in a ratio of 1:2V/V and the whole contents were
carefully layered over a lymphocyte separation medium
(Histopaque-1077) in a ratio of 3:1v/v in another sterile
centrifuge tube and centrifuged at 1500rpm for 40min
at room temperature to separate the lymphocytes. The
lymphocytes in a thin, white layer at the interface were
carefully pipetted out into next sterile tube containing 7mL
DPBS with antibiotics. Lymphocytes were washed twice in
DPBS and third time in culture medium by refrigeration
centrifugation at 1000rpm for 10 minutes in each wash.
After last wash culture medium was discarded and cells were
resuspended in 3mL culture medium (RPMI 1640 with 10%
FCS and antibiotics).
Trypanbluedyeexclusionmethodwasusedtodetermine
the proportion of viable cells in the separated lympho-
cytes. When the lymphocyte viability was above 95%, the
lymphocytes were processed further for culture. Culture
of lymphocytes was carried out in 96-well, tissue culture,
ﬂat bottom, sterile microplates with lid from Greiner Bio-
One, Germany. The cells were adjusted to 1 × 106 cells per
culture well. The culture medium used in present study
was RPMI-1640 from Sigma Chemical Co., St. Louis, MI,
USA, supplemented with L-glutamine, sodium bicarbonate,
sodium pyruvate, and antibiotics (Penicillin G and strep-
tomycin sulfate and antifungal amphotericin), besides 10%
fetal calf serum. 20μL of phytohemagglutinin (PHA-P) was
added per well to yield a concentration of 5μg/mL of culture
medium. 20μL of steroid hormone (working concentration)
was added to each well. The ﬁnal volume in each well
after adding mitogen and or sex steroid hormone was
made to 200μL with culture medium. Blank wells contained
only 200μL of culture medium with no cells, whereas S–
M and S + M wells contained no mitogen and mitogen,
respectively, besides lymphocytes. Every observation was
made in triplicate wells. The cells were cultured for 36 hours
at 37◦C in a humidiﬁed CO2 incubator (5% CO2). After
36 hours of incubation, 100μL of culture supernatant was
harvested in sterile 1.5mL eppendorf tubes and stored at
−20◦Cforestimationofnitricoxide.Equalvolumeofculture
media with supplements, preincubated at 37◦C, was added
intothewells.20μLoftheMTTsolution(5mg/mLdissolved
in DPBS and ﬁltered through 0.22μm Millex-GV ﬁlter unit)
was added to each well. The plates were again incubated for
4hr at 37 ◦C in humidiﬁed CO2 incubator. Thereafter, the
supernatant was pipetted out completely without disturbing
formazan crystal layer and 150μL of dimethyl sulfoxide
(DMSO) was added to each well. After incubating the plate
at room temperature for 15 minutes, it was shaken on a
microplate shaker and the optical density was read using
ELISA reader (Microscan MS-5608A) in dual wavelength
measuring system, at a wavelength of 570nm and a reference
wavelength of 630nm. Lymphocyte blastogenic response was
expressed as Proliferation Index (PI) and was calculated as
follows:
Proliferation Index (PI) = OD of the mitogen
stimulated cells/OD of
the unstimulated cells.
(1)
Inﬂuence of steroid hormone on lymphocyte blastogenic
activity was calculated by dividing optical density of
hormone-treated cells with optical density of mitogen-stim-
ulated cells.
Phytohemagglutinin used as a mitogen for prolifera-
tion of T-lymphocytes was made in culture medium at
50μg/mL. 10μLo fi tw a su s e df o re v e r y9 0 μLc u l t u r e
medium in each culture well to yield concentration of
PHA 5μg/mL. Stock solution of estradiol, progesterone,
and testosterone was prepared in ethanol which was
diluted with culture medium to working concentrations
of 10ng/mL, 5ng/mL, 1ng/mL, and 100pg/mL for estro-
gen, 10μg, 5μg, 1μg, and 100ng for progesterone, and
1000ng, 100ng, 10ng, and 1ng/mL for testosterone. 10μL
of working steroid solutions was added to every 90μL
culture medium in culture well yielding ﬁnal concentra-
tion of steroids as 1ng/mL, 500pg/mL, 100pg/mL, and
10pg/mL for estrogen, 1000ng/mL, 500ng/mL, 100ng/mL
and 10ng/mL for progesterone, and 100ng/mL, 10ng/mL,
1ng/mL, and 0.1ng/mL for testosterone. All the steroid hor-
mones, β-Estradiol, Progesterone (Δ4-pregnen-3-20-dione)Veterinary Medicine International 3
Table 1: Dose-dependent eﬀect of estradiol 17β on lymphocyte proliferation in vitro in Murrah buﬀaloes of diﬀerent sex and age.
Age group Sex
Estradiol 17β concentration (pg/mL) Sex∗
group mean Group mean Sex mean
10 100 500 1000
Group-I Male 0.98 ±0.03 1.04 ±0.04 0.93 ±0.04 0.87 ±0.04 0.95 ±0.02 0.95B± 0.01 0.97 ±0.01
(Male) Female 0.93 ±0.03 0.99 ±0.02 0.93 ±0.02 0.93 ±0.02 0.94 ±0.01
Group-II Male 0.95 ±0.04 1.01 ±0.05 0.97 ±0.04 0.91 ±0.01 0.96 ±0.02 0.95B± 0.01
Female 0.93 ±0.04 1.01 ±0.03 0.96 ±0.02 0.83 ±0.02 0.93 ±0.02
0.99 ±0.01
(Female) Group-III Male 0.91 ±0.02 1.12 ±0.06 1.07 ±0.05 0.86 ±0.05 0.99 ±0.03 1.04A± 0.01
Female 0.99 ±0.02 1.11 ±0.08 1.14 ±0.08 1.14 ±0.08 1.09 ±0.03
Treatment mean 0.95b± 0.01 1.05a± 0.02 1.00a± 0.02 0.93b± 0.02
Values with superscript a, b within same row and A, B within same column diﬀer signiﬁcantly (P<0.0 5 ) .C Da tt 5%: sex: 0.03, group: 0.04, treatment: 0.05,
sex∗ group: 0.06 and sex∗group∗treatment: 0.129.
and Testosterone (Δ4-androsten-17β-ol-3 one), Histopaque
1077, Phytohemagglutinin (PHA-P), Trypan blue, and Thi-
azolyl Blue Tetrazolium Bromide (MTT) were purchased
from Sigma Chemical Co., St. Louis, MI, USA. Dulbecco’s
Phosphate Buﬀered Saline (DPBS) was purchased from
Himedia Laboratories Pvt. Ltd. India.
Plasma nitric oxide was estimated as total nitrite (NOx)
using modiﬁed Griess reaction as described by Miranda
et al. [18]. The test involved preparation of Griess-I (1%
sulphanilamide w/v in 5% HCL) and Griess-II (0.1% N-
I-naphthyl ethylenediamine dihydrochloride w/v in milli-Q
water). The reagents were made fresh and ﬁltered before
use. The chemicals were purchased from Sigma Chemical
Co., St. Louis, MI, USA. 50μL of test culture supernatant
and standards (sodium nitrite at 1.56, 3.12, 6.25, 12.5, 25,
50, 100μM) prepared in culture medium was pipetted out
into a 96-well microtitre plate and blank wells contained
culture media only. The tests, blanks, and standards were
run in triplicates. 50μL Griess I (1% sulphanilamide) was
added to each well and held at room temperature for 5
minutes. 50μL Griess II was then added to each well and
plates were incubated at 37◦C for 30min. After incubation,
the absorbance was read at 540nm wavelength in ELISA
plate reader (Microscan MS-5608A). The concentration was
calculated from the standard curve using linear regression
equation.DetectionlimitofNOwas1.56μM.Inter-assayand
intra assay diﬀerence was 3.4% and 4.62%, respectively.
The data analysis was performed using Systat 12 software
package 2007 (Systat Software Inc. 1735 Technology Dr., Ste.
430, San Jose, CA 95110, USA). Analysis of variance of the
data was performed using three-way ANOVA with variables
age, sex, and concentration included in the model as ﬁxed
eﬀects and Tukey’s honestly signiﬁcant diﬀerence test was
employed. Values are presented as mean ± S.E. Graphs and
charts were prepared in Microsoft Excel 2007.
3. Results
3.1. Eﬀects of Sex Steroids on Lymphocyte Proliferation. The
eﬀect of four diﬀerent levels of estradiol (10, 100, 500, and
1000pg/mL) on lymphocyte proliferation response that was
calculated as proliferation index (PI), in buﬀalo lymphocytes
cultured in vitro, is presented in Table 1.P r o l i f e r a t i o n
response, irrespective of concentration of estradiol added,
was inhibited by 3 and 1%, respectively, in lymphocytes from
both male (0.97 ± 0.01) and female (0.99 ± 0.01) buﬀaloes
that did not diﬀer signiﬁcantly. However, signiﬁcant (P<
0.001) variation between age groups and treatment levels
was observed in the present study. Estrogen was found
inhibiting proliferation in group-I and group-II buﬀaloes by
5%ascomparedtogroup-IIIpostpubertalbuﬀaloeswhereit
stimulated the proliferation to the level of 4%. Among all the
groups, post pubertal female buﬀaloes registered the highest
(P<0.05) PI (1.09 ± 0.03) with estrogen treatment. Among
the four concentrations of estrogen, 100pg/mL registered
signiﬁcant (P<0.001) stimulatory eﬀect on PI (1.05 ± 0.02)
to the level of 5% as compared to 1000pg/mL (0.93 ± 0.02)
and10pg/mL(0.95±0.01)thatinsteadinhibitedlymphocyte
proliferation by 7% and 5% respectively.
Estrogen treatment of the lymphocytes collected from
cyclic buﬀaloes on day 10 registered signiﬁcantly (P<0.05)
higher stimulatory eﬀe c to nP It oa sh i g ha s1 0 %( 1 .10 ±
0.03) as compared to 3% (1.03 ± 0.01) on day 0 of estrous
cycle. Among the estrogen concentrations, 1000, 500, and
100pg/mL stimulated the lymphocyte proliferation (1.12,
1.10, and 1.07) signiﬁcantly (P<0.05) to the level of 12%,
10%, and 7%, respectively, whereas low level (10pg/mL)
inhibited proliferation (0.99 ± 0.03) up to 1% in cyclic
buﬀaloes. Thus, in cycling females only low level of estrogen
was found to be inhibitory to lymphocyte proliferation while
all other concentrations were stimulatory.
Eﬀects of progesterone treatment on in vitro prolifera-
tion of buﬀalo lymphocytes registered in present study are
presented in Table 2.
Though progesterone inhibited lymphocyte proliferation
signiﬁcantly (P<0.01) in both males and females, the
inhibitory eﬀect was severe in males (0.90 ± 0.01) to the
level of 10% as compared to females (0.97 ± 0.01) only
3%. There was no signiﬁcant diﬀerence in the eﬀects of
progesterone between diﬀerent age groups of buﬀaloes.
Progesterone inhibitory eﬀects were signiﬁcantly (P<0.001)
dose-dependent and PI was inversely proportional to the
progesterone concentration. The highest concentration of
progesterone (1000ng/mL) inhibited proliferation (0.81 ±
0.02) by 19% whereas the lowest (10ng/mL) registered4 Veterinary Medicine International
Table 2: Dose dependent eﬀect of progesterone on lymphocyte proliferation in vitro in Murrah buﬀaloes of diﬀerent sex and age.
Age group Sex
Progesterone concentration (ng/mL) Sex∗
group mean Group mean Sex mean
10 100 500 1000
Group-I Male 0.98 ±0.03 0.90 ±0.03 0.92 ±0.02 0.86 ±0.01 0.91 ±0.01 0.92 ±0.01 0.90 ±0.01
(Male) Female 0.99 ±0.07 0.96 ±0.04 0.93 ±0.02 0.83 ±0.04 0.92 ±0.02
Group-II Male 1.09 ±0.07 1.07 ±0.05 0.87 ±0.03 0.73 ±0.02 0.94 ±0.03 0.94 ±0.01
Female 1.01 ±0.01 1.00 ±0.04 0.89 ±0.02 0.76 ±0.01 0.94 ±0.02
0.97 ±0.01
(Female) Group-III Male 1.06 ±0.05 0.89 ±0.04 0.77 ±0.04 0.71 ±0.05 0.86 ±0.03 0.96 ±0.01
Female 1.14 ±0.07 1.07 ±0.05 1.05 ±0.05 0.99 ±0.03 1.06 ±0.02
Treatment mean 1.06a± 0.02 0.98b± 0.02 0.90c± 0.02 0.81d± 0.02
Values with diﬀerent superscript within same row diﬀer signiﬁcantly (P<0.05). CD at t 5%: sex: 0.03, treatment: 0.05, sex∗ group: 0.06 and sex∗ group∗
treatment: 0.123.
Table 3: Dose-dependent eﬀect of testosterone on lymphocyte proliferation in vitro in buﬀaloes of diﬀerent sex and age.
Age group Sex
Testosterone concentration (ng/mL) Sex∗
group mean Group mean Sex mean
0.10 1 10 100
Group-I Male 1.27 ±0.06 1.04 ±0.04 1.18 ±0.04 1.02 ±0.04 1.13 ±0.03 1.04 ±0.017 1.03 ±0.01
(Male) Female 0.97 ±0.03 0.94 ±0.02 0.94 ±0.02 0.98 ±0.03 0.96 ±0.01
Group-II Male 0.95 ±0.03 1.05 ±0.03 0.93 ±0.04 0.91 ±0.03 0.96 ±0.02 1.03 ±0.017
Female 1.11 ±0.05 1.140 ±0.04 1.08 ±0.05 1.07 ±0.03 1.10 ±0.02
1.05 ±0.01
(Female) Group-III Male 0.94 ±0.05 1.05 ±0.05 1.06 ±0.03 0.90 ±0.03 0.99 ±0.02 1.04 ±0.017
Female 1.06 ±0.06 1.08 ±0.05 1.12 ±0.05 1.14 ±0.09 1.10 ±0.03
Treatment mean 1.05 ±0.02 1.05 ±0.02 1.05 ±0.02 1.00 ±0.02
CD at t 5%: sex: 0.03, group: 0.04, sex∗ group: 0.06, sex∗ group∗ treatment: 0.13.
stimulatory eﬀect (1.058 ± 0.02) of 6%. Among all groups,
group-III post pubertal female buﬀaloes registered highest
(P<0.01) proliferation (1.065 ± 0.02) and group-III post
pubertal males the lowest (0.86 ± 0.03) when treated with
progesterone.
The progesterone eﬀects were not signiﬁcantly diﬀerent
between the lymphocytes from the day 0 and day 10
of reproductive cycle. However, dose dependent eﬀect of
progesterone on proliferation was signiﬁcant (P<0.01) with
highest concentration 1000ng/mL progesterone inhibiting
proliferation (0.976 ± 0.02) by 2% and 10ng/mL stimulated
proliferation(1.103±0.02)by10%.Thetrendinlymphocyte
proliferation with decreased dose of progesterone was linear.
The eﬀects of testosterone treatment on in vitro pro-
liferation of buﬀalo lymphocytes of diﬀerent sex and age
are presented in Table 3. Proliferation index was not found
to be diﬀerent in the two sexes in response to testosterone
supplementation in the culture. Males and females registered
stimulation in proliferation (1.026±0.01 and 1.05±0.01) to
the level of 2 and 5%, respectively. Testosterone in diﬀerent
concentration did not aﬀect the lymphocyte proliferation
signiﬁcantly. The highest concentration of 100ng/mL nei-
ther stimulated nor inhibited proliferation (1.00 ± 0.02).
Other treatments of 10, 1, and 0.1ng/mL concentration
did stimulate proliferation (1.05 ± 0.02, 1.052 ± 0.02, and
1.048±0.02) equally to the level of 5% which was statistically
nonsigniﬁcant between the concentrations. Testosterone
signiﬁcantly (P<0.01) inhibited proliferation by 4% in
group-II males but stimulated by 13% in group-I males,
irrespective of testosterone concentration. Contrary to this,
testosterone signiﬁcantly (P<0.01) inhibited proliferation
(0.958 ± 0.01) by 5% in group-I females but stimulated
(1.101 ±0.03) by 10% in group-III post pubertal females.
There was no signiﬁcant eﬀect of testosterone on lym-
phocyte proliferation index in cycling buﬀaloes. However,
proliferation was comparatively low in lymphocytes from
day 0 (1.049 ± 0.03) as compared to day 10 (1.104 ±
0.03) of estrous cycle when treated with testosterone. The
testosterone in all its concentrations stimulated proliferation
to the level of 10% (1.104 ± 0.04) at 10ng/mL and 5%
(1.049±0.04)at0.01ng/mLconcentrationincyclicbuﬀaloes.
3.2. Nitric Oxide Levels in Culture Supernatant. Nitric oxide
was evaluated in supernatant collected 36 hours after
lymphocyte culture (Figure 1). Males produced signiﬁcantly
(P<0.001) higher (8.52 ± 0.39μM/L) NO in culture
than females (6.13 ± 0.39μM/L). The diﬀerence was also
signiﬁcant (P<0.05) among the three groups with lowest in
group-III (6.23 ± 0.48μM/L), followed by group-II (8.07 ±
0.48μM/L) and group-I (7.68 ± 0.48μM/L). Among all
groups,group-IImalebuﬀaloesregisteredthehighest(9.89±
1.18μM/L) and group-III female buﬀaloes the lowest (4.87±
0.42μM/L) levels of nitric oxide in culture supernatant. In
cyclic buﬀaloes the nitric oxide concentration in culture
supernatant did not diﬀer signiﬁcantly with the stage of
estrous cycle and was 5.20 ± 0.29 and 4.88 ± 0.41μM/L on
day 0 (estrus) and day 10 (diestrus), respectively (Figure 1).Veterinary Medicine International 5
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Figure 1: NO culture supernatant in Murrah buﬀaloes of diﬀerent
sex, age, and stage of cycle.
Signiﬁcantly(P<0.001)higherlevelsofnitricoxidewere
recorded in culture supernatant of males (9.73 ± 0.30μM/L)
than females (6.75 ± 0.30μM/L) after 36 hours of culture
supplementedwithestradiol.TheNOlevelsinculturesuper-
natants supplemented with estradiol were signiﬁcantly (P<
0.001) diﬀerent between age groups with group-I buﬀalo
lymphocytes registering NO as high as 11.36 ± 0.37μM/L
followed by group-II and group-III (Figure 2). Among the
groups lymphocytes from group-I males registered highest
NO (14.01μM/L) in culture supernatant (Figure 2). There
was signiﬁcant (P<0.05) eﬀect of diﬀerent concentrations
of estrogen on nitric oxide levels in culture supernatant;
however, NO levels were maximum (8.77 ± 0.74μM/L)
at 100pg/mL concentration of estrogen and minimum at
10pg/mL level (Figure 3).
In cyclic buﬀaloes, NO in culture supernatant of day 10
(diestrous) lymphocytes was (5.30±0.44μM/L) signiﬁcantly
(P<0.001) higher than (3.47 ± 0.38μM/L) day 0 (estrous)
lymphocytes. Similarly diﬀerent concentrations of estrogen
in culture system had signiﬁcant (P<0.001) eﬀect on NO in
culture supernatant in cyclic buﬀaloes. Signiﬁcantly higher
levels of NO (5.82 ± 0.39μM/L and 5.51 ± 0.39μM/L) were
recorded at 100pg/mL and 500pg/mL estradiol, respectively,
as compared to (3.43 ± 0.93 and 2.79 ± 0.39μM/L) at
1000pg/mL and 10pg/mL estradiol, respectively, in cyclic
buﬀaloes (Figure 3).
Signiﬁcant (P<0.001) diﬀerence in levels of nitric
oxide in culture supernatant supplemented with diﬀerent
concentrations of progesterone was registered between the
sexes (6.58 ± 0.23 and 4.97 ± 0.23μM/L in males and
females resp.) and between the age groups (4.50 ± 0.28,
6.56 ± 0.28, and 6.24 ± 0.28μM/L in group-I, group-II,
& group-III buﬀaloes, resp.). Among the groups, group-II
males registered highest (P<0.05) levels of NO in culture
supernatant where as group-I females the lowest (Figure 4).
Similarly nitric oxide levels in culture supernatant diﬀered
signiﬁcantly (P<0.01) between various concentrations of
progesterone treatment (Figure 5).
Incyclicbuﬀaloes,phasesofcycleinﬂuencedsigniﬁcantly
the NO production in culture system. Lymphocytes from
day 10 registered signiﬁcantly (P<0.01) higher (5.68 ±
0.40μM/L) NO in culture supernatant as compared to
a
b
c
B
E
s
t
b
c c A
D
i
e
s
t
0
2
4
6
8
10
12
14
16
Male 
Female
Group-I Group-II Group-III Cycling
N
O
 
(
µ
M
/
L
)
Bars with diﬀerent superscript diﬀer signiﬁcantly (P<0.05)
Figure 2: NO in culture supernatant supplemented with estradiol
in Murrah buﬀaloes of diﬀerent sex, age, and stage of cycle.
day 0 (3.98 ± 0.40μM/L) (Figure 4). There was signiﬁcant
(P<0.01) decline in NO production with increasing
concentrations of progesterone supplementation with high-
est NO at 10ng/mL progesterone followed by 100, 500,
and 1000ng/mL progesterone respectively in cyclic buﬀaloes
(Figure 5).
Analysis of variance revealed signiﬁcant inﬂuence of sex
on nitric oxide production in culture supernatant supple-
mented with testosterone and male and female buﬀaloes on
an average, which produced 7.13±0.23 and 7.54±0.23μM/L
NO, respectively. Further, NO in culture supernatant was
signiﬁcantly (P<0.05) high (7.98 ± 0.29μM/L) in group-
II buﬀa l o e sa sc o m p a r e dt og r o u p - I I I( 7 .08 ± 0.29) and
group-I (6.96 ± 0.29μM/L). Among the all groups, group-
II male buﬀaloes recorded the highest (P<0.01) NO
whereas group-I males the lowest (Figure 6) .T h el e v e l sd i d
not vary signiﬁcantly in culture supernatant in response to
diﬀerent levels of testosterone (Figure 7). However, the levels
were comparatively higher (7.99±0.41μM/L) with 10ng/mL
supplementation.
In cyclic buﬀaloes, the estrous and diestrous phases
of reproductive cycle did not signiﬁcantly inﬂuence NO
production in culture supplemented with diﬀerent concen-
trationsoftestosteroneandmeanlevelsofNOinsupernatant
were 7.20 ± 0.35 and 6.62 ± 0.35μM/L in day 10 and day 0
lymphocyteculture,respectively(Figure 6).However,among
the testosterone concentrations, NO production at 0.1 and
100ng/mLconcentrationswassimilarandsigniﬁcantlylower
than at 1ng/mL and 10ng/mL (Figure 7).
4. Discussion
In vitro lymphocyte proliferation was measured in response
to supplementation of diﬀerent doses of estrogen in culture.
Estrogen inhibited proliferation slightly in lymphocytes of
group-Iandgroup-IIbutstimulatedingroup-IIIbuﬀaloesof
either sex. However, among four concentrations of estradiol,
100pg/mL was stimulatory in buﬀaloes of all ages of either
sex as compared to 1000 and 10pg/mL. These ﬁndings
reﬂect the dose-dependent eﬀect of estrogen on lymphocyte6 Veterinary Medicine International
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Figure 3: NO in culture supernatant supplemented with diﬀerent
levels of estradiol in Murrah buﬀaloes.
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Figure 4: NO in culture supernatant supplemented with proges-
terone in Murrah buﬀaloes.
proliferation.Possiblycertainlevelsofestrogenareimmuno-
stimulatory and enhance cell mediated immunity but at
the same time very high doses are immunosuppressive. An
interesting ﬁnding was that, in post pubertal females, estro-
gen at higher concentration also had stimulatory eﬀect on
lymphocyteproliferation.Thereisnoconsistencyinavailable
reports on lymphocyte proliferation delineating similar type
of response in relation to estrogen in diﬀerent animals.
Marco et al. [19] reported inhibitory eﬀects of estradiol on
lymphocyteproliferationinbothmalesandfemalesat50nM
concentration that upholds the present ﬁndings. Athreya
et al. [20] used 0.3 to 3ng/mL of estradiol and reported no
consistent eﬀects on human PBMCs proliferation in vitro.
Similarly Holdstock et al. [21] used estradiol at 40ng/mL in
culture and reported no signiﬁcant eﬀect of it on mitogen-
induced proliferation in humans. Bilbo and Nelson [12]
reported stimulatory eﬀect of estrogen at all levels on
lymphocyte proliferation in vitro in hamsters, contrary to
many other studies. All these ﬁndings suggest the charisma
of species variation in the eﬀects of estradiol on cell-
mediated immunity. Further, estrogen had diﬀerent eﬀects
onlymphocyteproliferationfromestrousanddiestrousstage
of reproductive cycle with signiﬁcantly higher stimulation
in diestrous phase lymphocytes than estrous. Since group-
III females in present study were actually progesterone
dominated therefore, to counteract the negative eﬀects of
immunosuppressive progesterone, estrogen even at higher
concentrations actually might have boosted the blastogenic
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Figure 5: NO in culture supernatant supplemented with diﬀerent
levels of progesterone in Murrah buﬀaloes.
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Figure 6: NO in culture supernatant supplemented with testos-
terone in Murrah buﬀaloes of diﬀerent sex, age, and stage of cycle.
activity of lymphocytes in diestrous cyclic buﬀaloes rather
than inhibiting as was true for other nonprogesterone phases
like estrous. These present results are comparable to the
ﬁndings of Sugiura et al. [22] who reported signiﬁcantly
enhanced response of dog PBMNCs collected in anestrus
to PYO-252 upon the addition of estradiol-17 beta to the
culture. There are reports of presence of steroid hormone
receptors in immune cells [23–27] and presence or absence,
upregulation or downregulation of receptors may be the
probable reason for the varied responses of lymphocytes
to estrogen treatment. There is possibility of diﬀerent
outcome of genomic and nongenomic pathway of steroid
actions on lymphocyte blastogenesis and depending upon
the receptor concentration stimulation or inhibition of
lymphocyte proliferation may be regulated. Therefore, it
seems important to investigate the receptor expression in
immune cells at diﬀerent proliferation responses to arrive at
a comprehensible conclusion.
Progesterone supplementation at diﬀerent concentra-
tionsinallbuﬀalogroupsofeithersexinhibitedproliferation
with more severe inhibition in males (10%) as compared
to females (3%). This sex-dependent variability in proges-
terone eﬀects may probably be due to the adaptation of
lymphocytes to progesterone because of being exposed toVeterinary Medicine International 7
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Figure 7: NO in culture supernatant supplemented with diﬀerent
levels of testosterone in Murrah buﬀaloes.
it in females. There was an inverse relationship between
the dose and proliferation index. The highest concentration
of progesterone (1000ng/mL) inhibited proliferation by
19% whereas the lowest (10ng/mL) registered stimulatory
eﬀect of 6%. These ﬁndings are in partial agreement with
those reported by Marco et al. [19]i nm i c ew h or e p o r t e d
inhibitory eﬀect of progesterone only in females. There are
several reports which indicate immunosuppressive eﬀects
of progesterone. R. Druckmann and M. A. Druckmann
[28] reported that progesterone up regulated progesterone
receptorsonlymphocytesinplacentaandwasresponsiblefor
production of progesterone-induced blocking factor which
favoursconceptionanddisfavourstherejectionofconceptus.
Su et al. [29] reported inhibitory eﬀects of progesterone
on immune response to lipopolysaccharide (LPS) through
modulating Toll-like receptor (TLR) signalling. Wulster-
Radcliﬀe et al. [9] in gilts and Kaushic et al. [6]i n
rodents reported that exogenous progesterone increased
the risk of development of diseases indicating inhibitory
eﬀects of progesterone on cell-mediated immune responses.
Sugiura et al. [22] examined the proliferative response of
PBMNCs to PYO-252 and reported signiﬁcantly decreased
response in the ﬁrst half (day 10) of estrous cycle, but
increased in proestrous/estrous and these responses were
signiﬁcantly suppressed in the presence of progesterone.
All these reports suggest the immunosuppressive eﬀects of
progesterone and in principle conﬁrm the present ﬁnding in
buﬀaloes with progesterone having inhibitory eﬀect on cell-
mediated immunity.
In current investigation, testosterone treatment stimu-
lated lymphocyte proliferation in both males and females to
the tune of 2 and 5%, respectively, with no signiﬁcant dose-
dependent eﬀect. Testosterone treatment in lymphocyte
culture did not yield any dependable and lucid eﬀects either
atanyparticulardoseorinanyagegroup.Ingroup-Imalesit
stimulated proliferation at all concentrations of testosterone
with maximum at 0.1ng/mL but in case of group-I female it
inhibited proliferation at all concentrations of testosterone.
In group-II males contrary to group-I males, testosterone
inhibited proliferation except at 1ng/mL concentration but
at the same time in group-II females it stimulated prolifera-
tion at all concentrations of testosterone with maximum at
1ng/mL. Whereas in group-III post pubertal males picture
was same as that of group-II males but in group-III females,
testosterone stimulated proliferation at all concentrations
with maximum at 100ng/mL. With these varied eﬀects of
testosterone, it is hard to arrive at any deﬁnitive conclusion.
Itmaybepossiblethatthelymphocytespossessthecapability
to convert testosterone into estrogen, which may govern the
proliferation in adult buﬀaloes. This option may be working
since we got similar observations with testosterone and
estrogen in post pubertal female lymphocytes. Benten et al.
[30] have demonstrated a membrane testosterone receptor
on lymphocyte enabling T cells a nongenomic response to
testosterone. Therefore, research in steroid receptors and
converting enzymes in lymphocytes is warranted. Bilbo and
Nelson [12] in hamsters found that both testosterone as
well as estradiol is stimulatory to lymphocyte proliferation,
whereas Marco et al. [19] in mice reported no signiﬁ-
cant eﬀect of testosterone on lymphocyte proliferation or
cytokine secretion. Roden et al. [13]r e p o r t e di m p r o v e d
immune responses including lymphocyte proliferation on
deprivation of testosterone in rodent model. Duﬀy et al. [31]
in wild male and female starling birds reported that implant
of testosterone signiﬁcantly reduced humoral immunity in
both males and females. All these reports indicate species
diﬀerences in testosterone eﬀects on immune responses.
Present ﬁndings revealed testosterone as stimulatory to
lymphocyte proliferation in buﬀaloes of all ages and sexes at
leastat1ng/mLconcentration.Although,currentknowledge
of sex steroid hormone eﬀects on immune function is
relatively limited to that of mice, rats, and humans [32, 33],
the results of the current study in buﬀaloes suggest a unique
roleforthesexsteroidsininﬂuencingimmunefunctionsthat
may have evolved along with the distinct natural history of
these animals.
4.1. Nitric Oxide in Culture Supernatant Cultured with Sex
Steroids. Sex and age bias in NO production by lymphocytes
in culture was evident in present study. Signiﬁcantly high
levels of NO were found in culture supernatant of males
as compared to females treated with estrogen. Among the
groups, group-I buﬀaloes had more NO in culture as
compared to group-II and III. However, production rate
was not aﬀected by increasing dose of estrogen in culture.
The proliferation was higher in group-III where NO was
lowest suggesting inverse relationship between PI and nitric
oxide production in culture and probably estrogen aﬀected
proliferationthroughNOlevelsinlymphocyteculture.How-
ever, the NO in culture supernatant of day 10 lymphocytes
was signiﬁcantly higher than day 0 while proliferation was
also signiﬁcantly high at diestrous than estrous phase. NO
has been reported to be secreted by lymphocytes [34, 35]
and blood leukocytes [36] in cattle. NO is liberated either
spontaneously or after cleavage by ectoenzymes found on T
a n dBl y m p h o c y t e si nb o v i n e s[ 35, 37].
Nitric oxide in lymphocyte culture treated with diﬀerent
concentrations of progesterone was signiﬁcantly high in
males as compared to females. Among the groups, sig-
niﬁcantly high levels of NO in culture supernatant were8 Veterinary Medicine International
found in group-III and least in group-I buﬀaloes. In cyclic
buﬀaloes, diestrous phase lymphocytes produced more NO
than estrous phase, treated with progesterone. Similarly
the nitric oxide levels in supernatant diﬀered between
the concentrations of progesterone with lowest NO at
highest progesterone concentration. The same trend was
also observed in lymphocyte proliferation. This suggested
that progesterone probably has no direct eﬀect on NO
production by lymphocytes and as such more proliferation
is accompanied with more NO.
NO in lymphocyte culture supernatant at any level
of testosterone did not show any signiﬁcant diﬀerence
between sexes with male and female buﬀa l o e so na na v e r a g e ,
producing 7.13±0.23 and 7.54±0.23μM/L NO, respectively,
in culture. This indicated that the lymphocytes obtained
from female animals were equally responsive to testosterone
as males. However, levels tended to be signiﬁcantly (P<
0.05) high in group-II buﬀaloes as compared to group-
I and III. In general, low levels of proliferation were
associated with less production of NO in culture in diﬀerent
age groups of buﬀaloes. Diﬀerences were not signiﬁcant
during diﬀerent stages of estrous cycle which suggested that
variations in the immune responses during estrous cycle
were not related to testosterone as was evident through PI
also.
Since it happens to be the ﬁrst report to register NO
in culture supernatant of lymphocytes from buﬀaloes of
diﬀerent sex and age with sex steroid treatment, it needs
further investigation before arriving at any ﬁnal conclusion
on relationship of sex steroids, NO, and lymphocyte prolifer-
ation.
5. Conclusion
Eﬀect of female sex steroids on lymphocyte proliferation in
vitro was found to be existing. Estradiol eﬀects were dose
dependent too, and high as well as too low levels of estradiol
were inhibitory to lymphocyte proliferation. Progesterone
was found to be inhibiting lymphocyte proliferation and
there was inverse relationship between progesterone dose
and lymphocyte proliferation. Testosterone did not show
any consistent and lucid eﬀects on lymphocyte prolifer-
ation, nor did it inhibit proliferation at any dose level.
The proliferation was higher in group-III where NO was
lowest suggesting inverse relationship between PI and nitric
oxide production in culture and probably estrogen aﬀected
proliferation through NO levels in lymphocyte culture. NO
was not the candidate mediator of eﬀects of all sex steroids
in lymphocyte proliferation. NO levels in supernatant
diﬀered between the concentrations of progesterone with
lowest NO at highest progesterone concentration and lowest
proliferation. This suggested that progesterone probably
has no direct eﬀect on NO production by lymphocytes
and as such more proliferation is accompanied with more
NO. No signiﬁcant diﬀerence in NO culture supernatant
was observed at diﬀerent concentrations of estradiol or
testosterone.
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